HealthDay - TUESDAY, Jan. 4 (HealthDay News) -- Just weeks after U.S. health officials moved to rescind approval of the drug Avastin to treat breast cancer, a new study provides more evidence that the anti-cancer medication ups the odds of congestive heart failure in these patients.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.